Experts Weigh In: Do You Need a Measles Booster?

With the United States, Mexico, and Bolivia recently losing their measles-free status, health experts are clarifying whether adults require additional vaccination.
Following the loss of measles-free status in the United States, Mexico, and Bolivia this week, public health experts are addressing inquiries regarding whether adults should seek a booster shot to enhance immunity against the virus.
For the general public, the answer is usually no. According to Dr. Richard Martinello of the Yale School of Medicine, most adults already possess sufficient protection either through childhood vaccination or by having recovered from the disease in the past.
The resurgence of the virus in the U.S., Mexico, and Bolivia follows stubborn outbreaks that have eroded decades of progress toward eradication. Canada faced a similar situation last year when it lost its measles-elimination designation.
Physicians maintain that the measles, mumps, and rubella (MMR) vaccine remains the most effective defense against one of the world’s most contagious viruses. Vaccination, like a natural infection, typically provides lifelong immunity. Individuals born before 1957 are generally considered to have “presumptive evidence” of immunity, as measles was widespread during their childhoods.
Despite the general consensus, some groups should consider getting a booster, experts note. This includes healthcare workers born before 1957 who lack proof of immunity, as they are at a higher risk of encountering and potentially spreading the virus to vulnerable patients.
Individuals who were vaccinated between 1963 and 1967 should also review their immunization records. During that period, some children received an inactivated vaccine—which used a killed version of the virus—that proved less effective than the current live, weakened vaccine. Experts advise anyone who received that specific vaccine, or who is uncertain of the formulation they received, to obtain at least one dose of the current live MMR vaccine.
Clinical data indicates that one dose of the modern vaccine provides 93% effectiveness, while two doses increase protection to 97%. Until 1989, a single dose was considered standard, but current guidelines recommend at least one documented dose for all adults, with two doses suggested for individuals in high-risk categories who lack other evidence of immunity.
Dr. Joshua Sharfstein, associated with the Johns Hopkins Bloomberg School of Public Health, suggests that those who have not received any doses should seek vaccination, unless they were born before 1957. “If they have had only one shot, they may want to consider whether they’re in a risk group for a second shot,” Sharfstein said.
These high-risk groups include international travelers, individuals in school environments, healthcare workers, and those living with family members who have compromised immune systems. In regions currently experiencing active measles outbreaks, health officials sometimes advise that the entire population ensure they have received two doses, Sharfstein noted.
For those unsure of their vaccination history, the Centers for Disease Control and Prevention recommends checking with family, former doctors, high school or college health services, or previous employers. Additionally, some state health departments maintain registries that may include adult vaccinations.
While blood tests for measles antibodies are available, Dr. Martinello cautioned that they do not perfectly correlate with an individual’s level of protection. For people who have received only one shot, particularly those in areas where the virus is currently circulating, discussing the necessity of an additional dose with a physician is a recommended step.
For the vast majority of the population, receiving a booster dose is not harmful, with the exception of specific groups such as pregnant women. As the virus circulates more broadly, experts encourage individuals to verify their own vaccination status and to facilitate the same for those around them.
“Too many people took measles for granted… or just didn’t think about measles,” Sharfstein observed. “But now it’s something to think about.”